Search

Your search keyword '"Selves A."' showing total 1,409 results

Search Constraints

Start Over You searched for: Author "Selves A." Remove constraint Author: "Selves A."
1,409 results on '"Selves A."'

Search Results

2. Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort

3. Sarcomas developed in patients with Lynch Syndrome are enriched in pleomorphic soft-tissue sarcomas and are sensitive to immunotherapy

4. Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre studyResearch in context

5. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

6. Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol

10. Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort

12. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

13. An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes

14. D-dimer Release From Livers During Ex Situ Normothermic Perfusion and After In Situ Normothermic Regional Perfusion: Evidence for Occult Fibrin Burden Associated With Adverse Transplant Outcomes and Cholangiopathy

15. PARP inhibitors and radiation potentiate liver cell death in vitro. Do hepatocellular carcinomas have an achilles’ heel?

16. Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI)

19. The cardiac output optimisation following liver transplant (COLT) trial: a feasibility randomised controlled trial

21. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes

22. The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program

25. MyotonPro Is a Valid Device for Assessing Wrist Biomechanical Stiffness in Healthy Young Adults

26. Peritoneal or mesenteric tumours revealing histiocytosis

27. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

28. The E3 ubiquitin ligase TRIP12 is required for pancreatic acinar cell plasticity and pancreatic carcinogenesis.

29. Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.

31. CCDC115-CDG: A new rare and misleading inherited cause of liver disease

33. Alteration of splicing factors’ expression during liver disease progression: impact on hepatocellular carcinoma outcome

35. D-dimer Release From Livers During Ex Situ Normothermic Perfusion and After In Situ Normothermic Regional Perfusion: Evidence for Occult Fibrin Burden Associated With Adverse Transplant Outcomes and Cholangiopathy

37. Cardiac output Optimisation following Liver Transplant (COLT) trial: study protocol for a feasibility randomised controlled trial

38. Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol

40. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation

41. Registration of ‘S17‐2243C’: A non‐genetically modified maturity group IV soybean cultivar with high yield and elevated oil concentration

42. Registration of ‘S16‐5503GT’ soybean cultivar with high yield, broad adaptation, and glyphosate tolerance

43. Subcostal transversus abdominis plane block for postoperative analgesia in liver transplant recipients: a before-and-after study

45. Registration of ‘S16‐11644C’: A maturity group IV soybean cultivar with high‐yielding performance and broad disease resistance

47. Identification of RP-6685, an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of Polθ

50. Post‐HCV cure self‐reported changes in physical activity, eating behaviours, and fatigue in people living with HIV (ANRS CO13 HEPAVIH)

Catalog

Books, media, physical & digital resources